These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3134521

  • 1. Further characterization of malignant glioma-derived vascular permeability factor.
    Criscuolo GR, Merrill MJ, Oldfield EH.
    J Neurosurg; 1988 Aug; 69(2):254-62. PubMed ID: 3134521
    [Abstract] [Full Text] [Related]

  • 2. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
    Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH.
    J Neurosurg; 1989 Dec; 71(6):884-91. PubMed ID: 2585081
    [Abstract] [Full Text] [Related]

  • 3. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
    Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH.
    J Neurosurg; 1987 Dec; 67(6):880-4. PubMed ID: 3681425
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH.
    J Clin Invest; 1996 Sep 15; 98(6):1400-8. PubMed ID: 8823305
    [Abstract] [Full Text] [Related]

  • 5. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG, Hasan T.
    Cancer Res; 1993 Jan 01; 53(1):153-7. PubMed ID: 8416739
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a protein product of human malignant glial tumors that induces microvascular permeability.
    Criscuolo GR, Merrill MJ, Oldfield EH.
    Adv Neurol; 1990 Jan 01; 52():469-74. PubMed ID: 2396540
    [No Abstract] [Full Text] [Related]

  • 7. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.
    Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF.
    Cancer Res; 1990 Mar 15; 50(6):1774-8. PubMed ID: 2155059
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM, Dvorak HF, Brock TA, Senger DR.
    Arch Biochem Biophys; 1993 Feb 15; 301(1):15-20. PubMed ID: 8442657
    [Abstract] [Full Text] [Related]

  • 9. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
    Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J.
    J Clin Invest; 1989 Nov 15; 84(5):1470-8. PubMed ID: 2478587
    [Abstract] [Full Text] [Related]

  • 10. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 11. Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line.
    Lobb RR, Key ME, Alderman EM, Fett JW.
    Int J Cancer; 1985 Oct 15; 36(4):473-8. PubMed ID: 4044056
    [Abstract] [Full Text] [Related]

  • 12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF.
    Cancer Res; 1993 Oct 01; 53(19):4727-35. PubMed ID: 8402650
    [Abstract] [Full Text] [Related]

  • 14. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 15. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM.
    Lab Invest; 1996 Feb 01; 74(2):546-56. PubMed ID: 8780172
    [Abstract] [Full Text] [Related]

  • 16. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF.
    Cancer Res; 1998 Mar 15; 58(6):1278-84. PubMed ID: 9515816
    [Abstract] [Full Text] [Related]

  • 17. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR, Perruzzi CA, Feder J, Dvorak HF.
    Cancer Res; 1986 Nov 15; 46(11):5629-32. PubMed ID: 3756910
    [Abstract] [Full Text] [Related]

  • 18. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
    Kondo S, Asano M, Suzuki H.
    Biochem Biophys Res Commun; 1993 Aug 16; 194(3):1234-41. PubMed ID: 7688963
    [Abstract] [Full Text] [Related]

  • 19. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF.
    Oncogene; 1997 May 01; 14(17):2025-32. PubMed ID: 9160882
    [Abstract] [Full Text] [Related]

  • 20. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
    Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D.
    J Exp Med; 1990 Dec 01; 172(6):1535-45. PubMed ID: 2258694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.